|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/541 | |
| A61K 9/20 | |||
| A61K 9/48 | |||
| A61K 31/437 |
| (11) | Patento numeris | 3102213 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15705777.9 |
| Europos patento paraiškos padavimo data | 2015-02-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-12-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-04-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2015/052239 |
| Data | 2015-02-04 |
| (87) | Numeris | WO 2015/117980 |
| Data | 2015-08-13 |
| (30) | Numeris | Data | Šalis |
| 201402070 | 2014-02-07 | GB |
| (72) |
DE WEER, Marc Maurice Germain, BE
VRIELYNCK, Sara Bertha Camiel, BE
SABOURAULT, Nicolas Luc, FR
MOESCHWITZER, Jan Peter, DE
|
| (73) |
Galapagos NV,
Generaal De Wittelaan L11/A3, 2800 Mechelen,
BE
|
| (54) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS |
| PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS |